CGTN: China Outlines Plan to Address Economic Challenges in Next 5 Years
China has set a gross domestic product (GDP) growth target of over six percent for 2021 and outlined a plan to promote innovation, green development, and common prosperity in the next five years.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210305005288/en/
Addressing the country's annual legislative session, Premier Li Keqiang on Friday explained how China is going to tackle the numerous challenges it faces in a new development stage.
"China remains in an important period of strategic opportunity for development. Yet, there are changes in both the opportunities and challenges we face," Li said when delivering a government work report at the opening meeting of the fourth session of the 13th National People's Congress (NPC), China's top legislature.
'Extraordinary year'
Describing 2020 as "an extraordinary year in the history of the People's Republic of China," the premier underscored China's "major strategic success" in fighting COVID-19 and the fact that it was the only major economy to achieve positive growth.
"We attained a complete victory in the fight against poverty, and we scored decisive achievements in securing a full victory in building a moderately prosperous society in all respects," Li said.
Key achievements in 2020:
- Major strategic success in COVID-19 response;
- GDP growth of 2.3 percent;
- A reduction of burden on market entities by over 2.6 trillion yuan ($402 billion);
- 11.86 million new urban jobs;
- Lifting the remaining 5.51 million poor rural residents out of poverty.
From 13th FYP period to 14th FYP period
China has made "historic new achievements" in economic and social development in the 13th Five-Year Plan (FYP) period (2016-2020), Li said in his report.
The country's GDP increased from less than 70 trillion yuan ($10.8 trillion) to over 100 trillion yuan ($15.5 trillion) over the past five years, he said, noting that over 60 million urban jobs were added.
The 14th FYP period (2021-2025) will be the first five years when China embarks on a new journey to build a modern socialist country in all respects, he stressed, before outlining the draft Outline for the 14th Five-Year Plan for Economic and Social Development and Long-Range Objectives through the Year 2035.
Main targets in the 14th FYP period:
- Major economic indicators to be kept within an appropriate range, and annual targets for economic growth to be set in light of actual conditions;
- Surveyed urban unemployment rates of within 5.5 percent;
- An annual increase of R&D spending by more than seven percent;
- An increase of permanent urban residents to 65 percent of the population;
- A reduction of energy consumption per unit of GDP and carbon dioxide emissions per unit of GDP by 13.5 percent and 18 percent, respectively;
- A raise of the average life expectancy by one year;
- Basic old-age insurance to cover 95 percent of the population.
These targets are set to improve the quality of economic growth, pursue innovation-driven development, create a robust domestic market, promote green development and improve people's well-being, according to the premier.
"Innovation remains at the heart of China's modernization drive," he said. The country will strive to make major breakthroughs in core technologies in key fields and formulate and implement a ten-year action plan for basic research, he added.
In order to foster a new development pattern, China will give priority to domestic circulation and work to build a strong domestic market and turn the country into a "trader of quality," he said.
"We will leverage the flow of the domestic economy to make China a major magnet for global production factors and resources, thereby promoting positive interplay between domestic circulation and international circulation," Li explained.
'A good start'
The Chinese government will take various measures this year to ensure "a good start" for the country in the 14th FYP period, Li said.
Main projected targets for development in 2021:
- GDP growth of over six percent;
- Over 11 million new urban jobs;
- A surveyed urban unemployment rate of around 5.5 percent;
- CPI increase of around three percent;
- Steady increases in both the volume and quality of imports and exports;
- A basic equilibrium in the balance of payments;
- Steady growth in personal income;
- A further improvement in the environment;
- A drop of around three percent in energy consumption per unit of GDP;
- A continued reduction in the discharge of major pollutants;
- Grain output of over 650 million metric tonnes.
China did not set a specific GDP growth target in 2020 amid uncertainty regarding the pandemic, but Premier Li announced a growth target of over six percent this year.
"A target of over six percent will enable all of us to devote full energy to promoting reform, innovation, and high-quality development," Li said.
The government will continue to implement and improve tax reduction policies, he said, announcing that the value-added tax (VAT) threshold for small-scale taxpayers will be raised from 100,000 yuan ($15,450) to 150,000 yuan ($23,175) in monthly sales.
"We will keep our prudent monetary policy flexible and targeted and at a reasonable and appropriate level," he said.
China's annual defense budget will maintain single-digit growth for a sixth consecutive year by increasing 6.8 percent in 2021, according to a draft budget report.
This year's planned defense spending will be about 1.35 trillion yuan ($209 billion), read the draft submitted to the fourth session of the 13th NPC for deliberation.
China's defense budget is about one-quarter of the U.S. figure, which is 740.5 billion U.S. dollars for the 2021 fiscal year.
'Patriots administering Hong Kong'
Li also stressed Beijing's stance on issues concerning the Hong Kong and Macao special administrative regions and Taiwan.
"We will improve the relevant systems and mechanisms of the two special administrative regions for enforcing the Constitution and the basic laws," he said. "We will ensure the implementation of the laws and enforcement mechanisms for the two regions to safeguard national security."
A draft decision on improving the electoral system of the Hong Kong Special Administrative Region (HKSAR) was submitted on Friday to the legislative session for deliberation.
In an explanatory speech on the draft, Wang Chen, vice chairman of the NPC Standing Committee, said the electoral system of the HKSAR should conform to "One Country, Two Systems," meet the realities in the HKSAR, and serve to ensure "patriots administering Hong Kong."
Commenting on the Taiwan question, Li reiterated commitment to the one-China principle and opposition to any separatist activity seeking "Taiwan Independence."
"We remain committed to the major principles and policies on work related to Taiwan, to the one-China principle and the 1992 Consensus, and to promoting the peaceful growth of relations across the Taiwan Straits and China's reunification," he said.
Challenges ahead
Despite the remarkable achievements in a highly challenging 2020, China still faces many challenges in the years to come, Li admitted.
"As COVID-19 continues to spread around the world, instability and uncertainty are mounting on the international landscape, and the global economy continues to face grave challenges," he underscored the unfavorable external environment.
"Domestically, there are still weak links in our work to control COVID-19," he continued, adding that the foundation for achieving economic recovery needs to be further consolidated.
As China strives to upgrade its economy, Li stressed that the country needs to improve its innovation capacity in key areas.
The premier also highlighted some local governments' "serious budgetary deficits" as well as the "formidable tasks" to forestall and defuse risks in the financial sector and other areas.
Addressing these challenges in its draft development plan, China is embarking on its new journey in a targeted approach.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210305005288/en/
Contact information
Media:
Jiang Simin
jiang.simin@cgtn.com
+86 18826553286
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
A-CAP Announces Successful Divestiture of Standard de Liège SA and Immobilière du Standard de Liège SRL6.6.2025 23:32:00 EEST | Press release
Advantage Capital Holdings, LLC (“A-CAP” or “The Company”), a New York-based insurance and financial services company with over $12 billion in assets, today announced the successful divestiture of Standard de Liège SA (“Standard Liège” or the “Club”), one of Belgium's most historic soccer clubs, and Immobilière du Standard de Liège SRL, the corporate entity that owns the Club's stadium, Maurice Dufrasne Stadium, to a consortium of buyers led by Standard Liège Chief Executive Officer Giacomo Angelini. This transaction marks the end of 777 Partners’ legacy involvement with the Club and sets the stage for the Club’s future growth and success, both on and off the field. Benefits of the transaction include: Increased stability across the Club’s shareholder base, which clears the path for future investments, Operational clarity, establishing a unified direction that will allow both players and management to fully concentrate on on-field performance, ensuring that collective focus remains on
Populous Acquires Fentress Architects, Expanding Global Aviation Portfolio6.6.2025 21:00:00 EEST | Press release
Populous, the world-renowned design firm specializing in sport and entertainment venues, today announced the acquisition of Denver-based Fentress Architects, a global leader in iconic aviation projects and prominent public buildings, including convention centers, museums and government facilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606849000/en/ Los Angeles International Airport. Designed by Fentress Architects. This strategic acquisition unites two of the most respected names in architecture, combining Populous’ unparalleled expertise in designing memorable experiences with Fentress’ award-winning portfolio of aviation, civic and cultural landmarks. The acquisition significantly broadens the scope and scale of services that Populous can offer clients across the globe. Bruce Miller, Populous Global Chair and CEO, commented: “We are committed to expanding the breadth of our practice. Fentress Architects has lon
Vertex Presents New Data on Benefits of ALYFTREK ® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference6.6.2025 19:00:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment with CFTR modulators and, in particular, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), which is approved in the United States and United Kingdom and is currently under review with health authorities in the EU, Canada, Australia, New Zealand and Switzerland. These data were presented at this year’s European Cystic Fibrosis Society’s (ECFS) 48th European Cystic Fibrosis Conference held June 4-7, 2025, in Milan, Italy. During the conference, the Company presented data from a pooled analysis across CFTR modulators, including ALYFTREK, which demonstrate that reduction in sweat chloride (SwCl), and therefore greater restoration of CFTR function, is associated with improved outcomes in people with cystic fibrosis (CF). For all clinical outcomes in the study, SwCl levels below 60 mmol/L were associated with greater benefit
IBSA Derma at IMCAS Asia 2025: spotlight on the future of aesthetic medicine in the 10 th Anniversary Year of NAHYCO ® Technology6.6.2025 17:00:00 EEST | Press release
IBSA Derma – the dermoaesthetic division of IBSA – once again confirms its leadership in the international aesthetic medicine landscape by participating in the 18th edition of IMCAS Asia, taking place from June 6 to 8 in Bangkok, Thailand. With over 3,000 attendees expected, the event represents a key opportunity for physicians and experts to share the latest innovations and cutting-edge advancements in aesthetic procedures and treatments, staying at the forefront of this dynamic field. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250603094257/en/ IBSA’s stand at IMCAS Asia 2025 As part of the congress, IBSA Derma will host a scientific symposium titled “The Future of Tissue Regeneration with NAHYCO® Technology. Feeling and Seeing the Results with Profhilo® Line” scheduled for Saturday, June 7, from 3:00 to 4:00 pm ICT in Room 1 - Level 2. Internationally renowned speakers – Dr. Lam Bee Lan and Prof. Ofir Artzi – will lead
HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-Invasive Histotripsy to Treat Kidney Tumors6.6.2025 15:00:00 EEST | Press release
HistoSonics, Inc., the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, today announced the completion of patient enrollment in its pivotal #HOPE4KIDNEY trial. This prospective, multi-center, single-arm trial is designed to evaluate the safety and effectiveness of the Edison System in destroying kidney tissue by treating primary solid kidney tumors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606659747/en/ Edison Histotripsy System Procedure for Kidney Tumor Animation The trial enrolled patients with a single, non-metastatic solid kidney mass ≤3 cm, confirmed by imaging and biopsy. Subjects will be followed for five years post-procedure, with evaluations at multiple time points, including 14-day, 30-day, 90-day, 180-day, and annual assessments. The Edison System remains in investigational use for kidney applications and is not yet FDA-approved for this indication. Data from the #H
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom